Revised diagnostic criteria for neurocysticercosis

被引:213
|
作者
Del Brutto, O. H. [1 ]
Nash, T. E. [2 ]
White, A. C., Jr. [3 ]
Rajshekhar, V. [4 ]
Wilkins, P. P. [5 ]
Singh, G. [6 ]
Vasquez, C. M. [7 ]
Salgado, P. [8 ]
Gilman, R. H. [9 ]
Garcia, H. H. [10 ,11 ,12 ]
机构
[1] Univ Espiritu Santo Ecuador, Sch Med, Guayaquil, Ecuador
[2] NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA
[4] Christian Med Coll & Hosp, Dept Neurol Sci, Vellore, Tamil Nadu, India
[5] Parasitol Serv, Marathon, FL USA
[6] Dayanand Med Coll, Dept Neurol, Ludhiana, Punjab, India
[7] Inst Natl Ciencias Neurol, Dept Neurosurg, Lima, Peru
[8] Natl Inst Neurol & Neurosurg Manuel Velasco Suare, Neuroimaging Unit, Mexico City, DF, Mexico
[9] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[10] Ctr Global Hlth, Tumbes, Peru
[11] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru
[12] Inst Natl Ciencias Neurol, Cysticercosis Unit, Jr Ancash 1271, Lima 1, Peru
基金
英国惠康基金;
关键词
Cysticercosis; Neurocysticercosis; Taenia solium; Diagnostic criteria; epilepsy; intracranial hypertension; BRUNS-SYNDROME; VENTRICULAR NEUROCYSTICERCOSIS; INTRACRANIAL CALCIFICATIONS; HUMAN CYSTICERCOSIS; COLLOID CYST; ASSAY; ALBENDAZOLE; MIMICKING; ENDOSCOPY; EPILEPSY;
D O I
10.1016/j.jns.2016.11.045
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A unified set of criteria for neurocysticercosis (NCC) has helped to standardize its diagnosis in different settings. Methods: Cysticercosis experts were convened to update current diagnostic criteria for NCC according to two principles: neuroimaging studies are essential for diagnosis, and all other information provides indirect evidence favoring the diagnosis. Recent diagnostic advances were incorporated to this revised set. Results: This revised set is structured in absolute, neuroimaging and clinical/exposure criteria. Absolute criteria include: histological confirmation of parasites, evidence of subretinal cysts, and demonstration of the scolex within a cyst. Neuroimaging criteria are categorized as major (cystic lesions without scolex, enhancing lesions, multilobulated cysts, and calcifications), confirmative (resolution of cysts after cysticidal drug therapy, spontaneous resolution of single enhancing lesions, and migrating ventricular cysts on sequential neuroimaging studies) and minor (hydrocephalus and leptomeningeal enhancement). Clinical/exposure criteria include: detection of anticysticercal antibodies or cysticercal antigens by well-standardized tests, systemic cysticercosis, evidence of a household Taenia carrier, suggestive clinical manifestations, and residency in endemic areas. Besides patients having absolute criteria, definitive diagnosis can be made in those having two major neuroimaging criteria (or one major plus one confirmative criteria) plus exposure. For patients presenting with one major and one minor neuroimaging criteria plus exposure, definitive diagnosis of NCC requires the exclusion of confounding pathologies. Probable diagnosis is reserved for individuals presenting with one neuroimaging criteria plus strong evidence of exposure. Conclusions: This revised set of diagnostic criteria provides simpler definitions and may facilitate its more uniform and widespread applicability in different scenarios. (C) 2016 The Authors. Published by Elsevier B.V.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [41] A new and revised diagnostic criterion for neurocysticercosis: Issues about diagnosis are still unresolved
    Garg, Ravindra Kumar
    Malhotra, Hardeep Singh
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 373 : 348 - 349
  • [42] Managing neurocysticercosis: challenges and solutions
    Fogang, Yannick Fogoum
    Savadogo, Abdoul Aziz
    Camara, Massaman
    Toffa, Denahin Hinnoutondji
    Basse, Anna
    Sow, Adjaratou Djeynabou
    Ndiaye, Mouhamadou Mansour
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2015, 8 : 333 - 344
  • [43] Update on the diagnosis and management of neurocysticercosis
    Takayanagui, Osvaldo Massaiti
    de Haes, Tissiana Marques
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (05) : 296 - 306
  • [44] Neurocysticercosis
    del Brutto, OH
    REVISTA DE NEUROLOGIA, 1999, 29 (05) : 456 - 466
  • [45] Neurocysticercosis
    Tscherpel, C.
    Gottschalk, A.
    Meyding-Lamade, U.
    Fink, G. R.
    Burghaus, L.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (08) : 451 - 454
  • [46] Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study
    Stelzle, D.
    Makasi, C.
    Schmidt, V.
    Trevisan, C.
    Van Damme, I.
    Ruether, C.
    Dorny, P.
    Magnussen, P.
    Zulu, G.
    Mwape, K. E.
    Bottieau, E.
    Prazeres da Costa, C.
    Prodjinotho, U. F.
    Carabin, H.
    Jackson, E.
    Fleury, A.
    Gabriel, S.
    Ngowi, B. J.
    Winkler, A. S.
    INFECTION, 2023, 51 (04) : 1127 - 1139
  • [47] New guidelines for the diagnosis and treatment of neurocysticercosis: a difficult proposal for patients in endemic countries
    Carpio, Arturo
    Fleury, Agnes
    Kelvin, Elizabeth A.
    Romo, Matthew L.
    Abraham, Ronaldo
    Tellez-Zenteno, Jose
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (10) : 743 - 747
  • [48] Clinical Manifestations, Diagnosis, and Treatment of Neurocysticercosis
    Julio Sotelo
    Current Neurology and Neuroscience Reports, 2011, 11 : 529 - 535
  • [49] Neurocysticercosis: an update on diagnosis, treatment, and prevention
    Pineda-Reyes, Roberto
    White, A. Clinton, Jr.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2022, 35 (03) : 246 - 254
  • [50] Caveats to the application of the revised diagnostic criteria for paraneoplastic pemphigus
    Svoboda, Steven
    Baghchechi, Mohsen
    Rees, Adam
    Motaparthi, Kiran
    JOURNAL OF CUTANEOUS PATHOLOGY, 2024, 51 (09) : 685 - 688